Skip to main content

Table 3 Presence of herpesviruses DNA according to the different chemotherapy phases as detected by multiplex PCR

From: Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy

Viral detectionBefore chemotherapy
N = 95 (%)
Post- induction
N = 95 (%)
Post -remission
N = 70 (%)
After salvage
N = 29 (%)
All periods
N = 289 (%)
CMV8 (8.4)14 (14.7)19 (27.1)15 (51.7)56 (19.4)
EBV1 (1)3 (3.15)2 (2.8)2 (7)8 (2.7)
HHV-61 (1)8 (8.4)9 (12.9)10 (34.5)28 (9.7)
HHV-71 (1)6 (6.3)3 (4.2)5 (17.2)15 (5.2)
Patients negative for all86 (90.5)74 (78)46 (65.7)7 (24.1)213 (73.7)
Patients positive for 1 or more detection9 (9.5)21 (22)24 (34.3)22 (75.9)76 (26.3)
  1. The prevalence of viral infections during the different phases of chemotherapy: before chemotherapy, post-induction, post-remission and after salvage
\